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As the application of computational methods in drug discovery pipelines becomes more widespread 
it is increasingly important to understand how reproducible their results are and how sensitive they 
are to choices made in simulation setup and analysis. Here we use ensemble simulation protocols, 
termed esMACs (enhanced sampling of molecular dynamics with approximation of continuum 
solvent), to investigate the sensitivity of the popular molecular mechanics poisson-Boltzmann surface 
area (MMPBSA) methodology. Using the bromodomain-containing protein 4 (BRD4) system bound 
to a diverse set of ligands as our target, we show that robust rankings can be produced only through 
combining ensemble sampling with multiple trajectories and enhanced solvation via an explicit ligand 
hydration shell.
The discovery and design of novel drugs is immensely expensive, with one study putting the cost of each new 
therapeutic molecule that reaches the clinic at US$1.8 billion1. A diversity of computational approaches, specif-
ically binding free energy calculations which rely on physics-based molecular dynamics simulations (MD) have 
been developed2, and blind tests show that many have considerable predictive potential3,4. In this context, recent 
developments in algorithms and hardware that have reduced the cost and time of these computational approaches 
have seen an increase in their appeal to the pharmaceutical industry5–9. With commercial approaches that claim 
accuracy of below 1 kcal mol−1 now on the market10 it is becoming of increasing interest to understand the accu-
racy of and uncertainties inherent in different approaches11. These concerns echo wider interest in the scientific 
community in the lack of reproducible results in the published literature12,13.
One of the most common computational binding affinity prediction techniques is molecular mechanics 
Poisson–Boltzmann surface area (MMPBSA)14. This is an approximate post-processing end-state method, which 
uses continuum solvent models to reduce the computational cost of obtaining results. The speed and ease of setup 
(compared to rigorous free energy calculations) make MMPBSA an attractive candidate for use throughout the 
drug discovery pipeline. However, results are often seen to be system dependent and are widely perceived to be 
less accurate than those obtained from more expensive and theoretically rigorous approaches (such as free energy 
perturbation, FEP, and thermodynamic integration, TI)2,15. Furthermore, the term MMPBSA as used in the lit-
erature permits a wide range of variants which incorporate different sampling strategies (for example, all ligand 
conformers can be drawn from simulation of the complex or from independent runs) and differing solvation 
and entropy terms. Our previous work has demonstrated that MMPBSA analysis of single simulations is highly 
unreliable with calculations initiated from the same structures varying by up to 12 kcal mol−1 for small molecules 
bound to HIV-1 protease and even more for flexible ligands binding to MHC16,17. This served as the inspiration 
for our ESMACS (enhanced sampling of molecular dynamics with approximation of continuum solvent) proto-
cols which use ensemble simulations that have been shown to produce results with reproducible uncertainties of 
less than 2 kcal mol−1 for a range of systems9,16,18. In this work we seek to assess the performance of the approach 
in a challenging dataset containing a highly varied set of ligands which interact with water in the protein binding 
site. We assess the impact on protocol performance of multiple trajectory sampling, ligand parameterization, 
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inclusion of explicit water molecules and a recently developed approach to calculating the entropic contribution 
to the binding free energy.
The target of our investigation is the bromodomain-containing protein 4 (BRD4). Bromodomains are a major 
and rapidly evolving focus for the pharmaceutical industry with inhibitors targeting them having shown promising 
pre-clinical efficacy in pathologies ranging from cancer to inflammation. BRD4, in particular, has recently become 
something of a benchmark system for free energy calculations15,19–21, including for those based on MMPBSA22.
Computational Methods
The principle behind the ESMACS family of protocols is that many short simulations provide better sampling 
than single long simulations, facilitating the rapid and reproducible calculation of binding affinities using var-
iations of MMPBSA. The ESMACS simulation and analysis workflow has been automated using the Binding 
Affinity Calculator (BAC)23 which we have recently enhanced using Radical Cybertools24,25 to create HTBAC26. 
The goal of HTBAC is to provide a programmable interface to create computational pipelines built from selected 
software tools and services, and execute them on remote resources. It automates much of the complexity of run-
ning and marshalling the molecular dynamics simulations, as well as collecting and analyzing data.
Our ESMACS protocols are flexible, allowing for the analysis to be tailored to the target system. Previous 
targets we have studied include small molecule inhibitors of HIV proteins18,27,28, kinases8,29 and larger more flex-
ible ligands such as peptides which bind to MHC17. In all these studies correlation coefficients of better than 0.7 
were obtained. MMPBSA is most commonly used to assess binding affinities from a single trajectory of a protein 
bound to its target ligand but in this work we explore the influence of protein and ligand flexibility using inde-
pendent trajectories.
Free energy of binding computations. When two reactants combine at constant temperature and pres-
sure the binding affinity is characterized by the change in Gibbs free energy, ΔG. MMPBSA is an endpoint free 
energy calculation; in such methods ΔG is calculated using:
∆ = 〈 〉 − 〈 〉 − 〈 〉G G G G , (1)complex receptor ligand
where 〈 〉Gcomplex , 〈 〉Greceptor  and 〈 〉Gligand  are the average values of the Gibbs free energy for the complex, receptor 
(protein) and ligand respectively.
Sampling of the complex and its two components can be performed independently or conformations of the 
receptor and ligand extracted from simulation of the complex. The latter approach is more commonly used due 
to its improved convergence behaviour, a consequence of cancellation between the noisy terms describing the 
internal energy of the ligand, receptor and complex30. However, recent work has indicated that adaptation ener-
gies associated with confining the receptor and ligand in a complex can differ significantly even for closely related 
complexes9. Here we investigate a range of ESMACS protocols incorporating different component sampling strat-
egies. When both the receptor and ligand contributions are computed from the complex trajectory we designate 
this a “1traj protocol”. When all three derive from independent trajectories we refer to this as the “3traj protocol” 
and when only one or other of the receptor or ligand contributions do so a “2traj protocol”. A suffix (either -fl 
or -fr, for flexible ligand and receptor respectively) is added to the protocol name to signify which component is 
derived from the independent simulation. Additional variants involve the use of the average receptor contribution 
across the complex simulations for all comparable ligands, which is indicated with an –ar (averaged receptor) suf-
fix in the protocol name. A summary of all of the protocols, describing from which simulation component data is 
obtained, is given in Table 1. It should be noticed that the statistical performance of the pair of protocols 1traj-ar 
and 2traj-fr, and 2traj-ar and 3traj are the same, as the receptor contribution in all cases is constant. Consequently, 
we do not analyze the 3traj or 2traj-fr protocols explicitly.
The binding free energy change calculated by MMPBSA (ΔGMMPBSA) can be broken down into a number of 
components:










Contribution to the binding free energy
Complex Receptor Ligand
1-traj C C C
1-traj-ar C Constant C
2-traj-fr C R C
2-traj-fl C C L
2-traj-ar C Constant L
3-traj C R L
Table 1. Summary of the origin of component contributions in 6 ESMACS protocols indicating whether they 
come from the ensemble of simulations run for the complex (C) or separate ensembles performed for the 
receptor (R) and ligands (L). Constant refers to the use of a constant, usually the average value across the studied 
systems.





MM are the electrostatic, van der Waals and the internal bonded contributions to 
the molecular mechanics free energy difference, respectively, and ΔGpol
sol  and ΔGnonpol
sol  are the polar and non-polar 
solvation terms, respectively.
The MMPBSA.py31 program, provided as part of the AmberTools 14 package32, was used in the evaluation of 
all components of the MMPBSA calculation. The electrostatic free energy of solvation, ΔGpol
sol , is the part of the 
calculation described by the Poisson-Boltzmann (PB) calculation. Default values were used for the PB calculation 
(grid spacing of 0.5 Å, internal and external dielectric constants of 1 and 80, respectively). The non-polar solva-
tion free energy calculation is calculated from the solvent accessible surface area using the traditional one com-
ponent method (specified using inp = 1 in the input file). In this approach the surface tension, γ, is set to 
0.00542 kcal mol−1 Å−2) and the off-set, β, to 0.92 kcal mol−1. The fill ratio parameter was set to 4.0 which does not 
impact the results but ensures the stability of the calculations. For calculations in which explicit water molecules 
were incorporated as part of the receptor, the closest N molecules to the ligand were chosen for inclusion.
Entropic contribution to binding free energies. A variety of options are available to incorporate entropic contri-
butions to ΔG. The most common approach is normal mode analysis33,34 but it can require similar computational 
effort to the underlying simulations in order to obtain converged results18. Consequently, here we explore the use 
of another, more computationally efficient, alternative approach proposed by Duan et al.35. In their formulation 
the “variational entropy” can be derived from the fluctuations of the receptor-ligand interaction energy, Einter. This 
energy can be calculated using components of the MMPBSA calculation:




The fluctuation in interaction energy is then given by:
∆ = − 〈 〉E E E , (4)inter inter inter
where angle braces indicate an ensemble average. This is then used to compute the entropic contribution to 
binding via:
− ∆ = 〈 〉β∆T S k T eln (5)var B
Einter
where kB is the Boltzmann constant and β = k T1/ B .
Figure 1. Overview of the ESMACS workflow. The 1traj protocol is shown in (a) consisting of an ensemble of 1 
to N (25 in this study) simulations of the protein-ligand complex. Each simulation is made up of (min)imization 
and two (eq)uilibration steps and a single production NAMD run which are each analyzed independently 
using the MMPBSA.py script. The output of the analysis is then collated and bootstrap statistics produced. The 
multiple trajectory approaches, shown in (b) follow a similar outline but with independent trajectories also run 
of the ligand system alone.
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simulation setup. Ensembles of 25 replica MD simulations were conducted using the package NAMD 
2.1136 for each system (complex, receptor or ligand) studied. All simulations were conducted using the protocol 
incorporated into BAC23. We have previously shown that the use of 25 replica ensembles provides a good balance 
of computational cost and calculation uncertainty for a number of varied systems8,17,18.
Each system was minimized with all heavy protein atoms restrained at their initial positions (with a restrain-
ing force constant of 4 kcal mol−1 Å−2). Initial velocities were then generated independently for each replica from 
a Maxwell–Boltzmann distribution at 50 K. Each system was virtually heated to 300 K over 60 ps and subsequently 
maintained at this temperature using a thermostat (employing a coupling coefficient of 1 ps−1) during which 
time the restraints applied during minimization were retained. Once the system reached the correct temperature 
the pressure was maintained at 1 bar using a Berendesen barostat (with a pressure coupling constant of 0.1 ps). 
Subsequent to the heating, a series of equilibration runs, totaling 2 ns, were conducted, during which the restraints 
on heavy atoms were gradually reduced. The restraint reduction occurs in ten 100 ps steps, after each one the force 
constant was halved. Finally, 4 ns production simulations were executed with snapshots output for analysis every 
100 ps. A 2 fs time step was used for all MD simulation steps. The workflow of the ESMACS protocols is shown 
in Fig. 1. For each system run through the 1traj protocol an ensemble of independent NAMD simulations is exe-
cuted, consisting of four steps. The first minimization (min), which is followed by two equilibration steps (labelled 
eq1 and eq2 respectively). In Eq. 1 the system is heated while restraints are applied to heavy atoms. In Eq. 2 
restraints are gradually reduced before free simulation is undertaken. After 2 ns of aggregate equilibration the 4 ns 
production phase is initiated. It is the production trajectory which is analysed by MMPBSA.py. A script is then 
run to aggregate these results from the ensemble of simulations and values of ΔGMMPBSA computed along with 
bootstrap statistics. In multiple trajectory approaches a second ensemble of ligand-only simulations is conducted 
and fed into the aggregation and bootstrapping script. Full simulation details are provided in the main text.
experimental Datasets. This study investigates a combination of BRD4 ligand binding datasets which have been 
the subjects of earlier studies. The first, previously studied by Aldeghi et al.15 using a combination of FEP based abso-
lute binding free energy and MMPBSA techniques, contains a diverse set of 11 ligands which will be referred to as the 
diverse (DIV) dataset. The second was recently studied by our group in collaboration with GlaxoSmithKline9 (using 
a combination of ESMACS and ensemble thermodynamic integration approaches) and contains 16 ligands, all based 
on a single tetrahydroquinoline (THQ) template (consequently we identify this as the THQ dataset). The compounds 
were selected to represent a range of chemical functionality and binding affinities, despite their shared scaffold. The 
first 11 compounds are labeled 1 to 9 according to the scheme used by Aldeghi et al.15, the THQ based ligands are 
labeled THQ1 to THQ16 (the numbers correspond to those used in Wan et al.9). The chemical structure of the first 11 
compounds and the THQ scaffold are shown in Fig. 2. Details of the groups found at positions R1 to R4 in the THQ 
based ligands are detailed in Fig. 3 and Table 2. Ligand 4 was parameterized with a charge of +1. Compounds THQ10 
to THQ12 and THQ16 are positively charged (+1), and compounds THQ13 to THQ15 are negatively charged (−1).
Experimental binding free energies (ΔGexpt) for the first dataset were obtained from a combination of SPR, 
Alphascreen and Isothermal Titration Calorimetry (ITC) experiments15, whereas those for the THQ dataset are derived 
from IC50 values from FRET9. These techniques are very different from one another and will necessarily introduce var-
ying levels of uncertainty into the data they provide. The divergence in the origin of the measurements is representative 
of the sources of experimental data to which free energy calculations are typically compared. This, alongside the lack 
Figure 2. Chemical structures of ligands from the BRD4 dataset previously studied by Aldeghi et al.15 (1–11) 
and the tetrahydroquinoline (THQ) scaffold. Full R-group information for the THQ dataset ligands is provided 
in Fig. 3 and Table 2.
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of rigorously derived uncertainty estimates in the experimental data, must be borne in mind when assessing protocol 
performance. In Table 3 we provide the full experimental binding affinities for both the diverse (DIV) and tetrahydro-
quinoline scaffold (THQ) datasets.
structural models. The ligands from both datasets were simulated bound to the two BRD4 structural models 
based on PDBs 2OSS and 4BJX respectively (these are the initial structures used in Aldeghi et al.15 and Wan et al.9). The 
former represents the apo BRD4 and the latter the protein bound to a THQ based ligand. The secondary structure of 
both models is very similar (see Fig. 4a) and the RMSD between the two structures is 0.44 Å. All crystallographic water 
molecules were retained, including four which are conserved in the binding site of both models. The poses of the lig-
ands in the DIV dataset were extracted from crystal structures (PDBs: 3U5J, 3U5L, 4OGI, 4OGJ, 3MXF, 4MR3, 4MR4, 
3SVG, 4J0R and 4HBV), except for one ligand, labelled 10, which was modeled (based on PDB 3SVG) and docked 
into 2OSS as two conformers. These are the same two conformers used in Aldeghi et al.15, differing by a 180° flip of the 
trifluorophenyl moiety. The modelled poses were aligned and copied into the 4BJX based models. Poses of the THQ 
ligands were based on that of I-BET726 as found in the 4BJX structure.
System setup, including the creation of a water box and addition of neutralizing ions, was performed using 
AmberTools 1737,38. The majority of simulations were conducted using protein parameters taken from the stand-
ard Amber force field for bioorganic systems (ff14SB)39. Reproducibility studies of the THQ ligands were con-
ducted using an earlier version of the forcefield, ff99SBildn40.
Drug parameters were produced using the general Amber force field (GAFF)41. The majority of the simula-
tions presented here employ ligands prepared using the Gaussian/RESP protocol. In this approach, Gaussian 9842 
was used to perform geometric optimization of the inhibitor with 6–31G** basis functions, and the restrained 
electrostatic potential (RESP) procedure was used to calculate the partial atomic charges. Reproducibility studies 
Ligand ID R1 R2 R3 R4
THQ1 H Me Me (a)
THQ2 H Me Me H
THQ3 H Me Me (f)
THQ4 H Me Me (b)
THQ5 H Me Me (c)
THQ6 H Me Me (d)
THQ7 H Me Me (e)
THQ8 H Me Et (f)
THQ9 H Me i-Pr (f)
THQ10 H Me Me (g)
THQ11 H Et Me (g)
THQ12 H Pr Me (g)
THQ13 H Pr Me (h)
THQ14 H Et Me (h)
THQ15 Cl Me Me (h)
THQ16 H Me Me (g)
Table 2. Composition of the ligands of the THQ dataset. The groups found at R4 are shown in Fig. 3(a–h), with 
the common THQ scaffold in Fig. 3(i). Compounds THQ1–9 are neutral, 10–12 and 16 are positively charged 
(+1), and 13–15 negatively charged (−1). All compounds are the 2-(S) 4-(R) isomers except compound 16 
which is 2-(R) 4-(S).
Figure 3. (a–h) Structures of the groups of the side groups which are added to the tetrahydroquinoline (THQ) 
scaffold shown in (i) to create the ligands in the THQ dataset. Full composition information for the ligands is 
provided in Table 2.
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of the DIV dataset were conducted using AM1-BCC43 derived charges. All charge assignment and input file gen-
eration was performed in the Antechamber component of AmberTools.
statistics and uncertainties. All statistics presented use their standard definitions with the exception of the 
mean unsigned error (MUE). It is well known that MMPBSA results have a significant offset from experimental values 
(typically of the order of 15 to 25 kcal mol−1) due to a range of factors, in particularly the neglect of entropic contribu-
tions33,34. Consequently we present values corrected for the systematic (mean signed) error and designate them cMUE.
We compute uncertainties for all metrics through bootstrapping analysis. This method involves resampling with 
replacement the N input data points (in this case, the replica averages of ΔGMMPBSA) to provide a new bootstrap 
sample also containing N data points. This process is repeated many times (in our case 5000 times) and the statistic 
of interest of each bootstrap population calculated. The standard deviation of these values provides an estimate of 
the uncertainty associated with an average derived from a given sample; this is what is quoted as the bootstrap error 
measure of our statistics. For correlation coefficients samples are drawn from the overall averages for each ligand 
paired with the relevant experimental value. In addition to this metric, when making a direct comparison of specific 
correlation coefficients we will also quote 95% confidence intervals. These intervals are calculated by sorting the 
bootstrap sample distribution of correlation coefficients and taking the values falling at the 2.5 and 97.5 percentiles.
Results
Here we evaluate the performance of a range of ESMACS protocols in reproducing the experimental rankings 
across the full diverse ligand dataset, the robustness of this ranking to choices in system setup and the influence 
of non-standard MMPBSA components.
standard esMACs performance and Robustness to Initial structure Variation. Comparison of the 
results of all ESMACS protocols across the full DIV + THQ dataset shows a distinct trend in which inclusion of the 
receptor average energy considerably improves the predictions obtained for both initial protein models. In both 
cases 1traj results have a Spearman rank coefficient, rs, of 0.46 [CI: 0.16–0.84 for both] which improves to 0.66 [CI: 
0.50–0.94]/0.60 [CI: 0.40–0.91] (2OSS/4BJX) when both ligand and receptor flexibility are accounted for in the 
2traj-ar protocol. In the DIV dataset better ranking can be obtained using receptor flexibility alone, but in order to 
obtain good rankings for THQ both additional contributions are required. This is the same behaviour observed in 
the simulation results for the THQ dataset in Wan et al.9; however the overall ranking is worse (the original study 
obtained an rs of 0.78 [CI: 0.53–0.92]), primarily due to the stronger predicted binding affinity for the experimentally 
least potent drug, THQ16, in the present study.
The improvement between 1traj and 2traj-ar is illustrated in Fig. 5, which shows that outliers are moved closer 
to the overall trend line (particularly apparent for the DIV ligands 3, 4 and 5 which were also outliers in Aldeghi 
et al.15). These three ligands have similar experimental binding energies but a difference of 15 kcal mol−1 in 1traj 
and 10 kcal mol−1 in 2traj-ar is seen in ΔGMMPBSA The ranking improvement is larger for the THQ ligands than 
the DIV dataset, with the 1traj results exhibiting little if any correlation with experiment. The main THQ outliers 
in the 1traj results are THQ12, THQ13 and THQ9. The first two are moved closer to the trend in the 2traj-ar 
results but THQ9 remains more negative than might be expected. Another feature of the 2traj-ar data here is that 
greater separation is seen between the results obtained from the two BRD4 structures for TH12, THQ13 and most 
Figure 4. BRD4 structure in cartoon representation with conserved binding site waters shown as van der Waals 
spheres. (a) A comparison of the structural models created as derived from the 2OSS (green) and 4BJX (purple) 
PDBs. (b) The initial binding mode of ligand 1 (shown in chemical representation) in the 2OSS derived BRD4 
structure.
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pronouncedly THQ16. This is in contrast to nearly all other ligands where the values obtained from simulations 
with either model are well within the error margin, many sitting on top of one another in Fig. 5.
It can also be seen in Table 4 that the impact of the incorporation of receptor ‘strain’ in the 1traj-ar and 2traj-ar 
protocols is different in the DIV and THQ subsets. In the 4BJX simulations the DIV rankings are notably less 
good than that in the 1traj, whilst they are fairly similar in the 2OSS case. Whereas for THQ, we find that account-
ing for the receptor and ligand flexibility is necessary to obtain a good ranking in both cases. Overall the results 
from the 2OSS structure are better than those from 4BJX. However, it should be noted that the ΔGMMPBSA values 
for all drugs using the 1traj protocol agree within error (see Fig. 5a).
Robustness of Ranking to parameterization. Two of the key decisions in ligand binding free energy 
calculations are the choices of the forcefield and how small molecules are parameterized. For simulations 
using Amber forcefields the choice of procedures for ligand preparation is usually whether to use AM1-BCC 
or Gaussian/RESP based protocols to determine atom charges in combination with the GAFF general purpose 
forcefield parameters. Following the choice in Wan et al.9 we used Gaussian/RESP for the majority of simula-
tions in this work, but to evaluate the influence of this we re-ran the DIV dataset in the 2OSS model using the 
AM1-BCC methodology. Figure 6a shows that the ΔGMMPBSA values for the large majority of the ligands are 
highly correlated between the two schemes (within 1–2 kcal mol−1). This and the similar correlation with experi-
ment (shown in Table 5) indicates that our results are robust with respect to this choice.
The Wan et al.9 study employed the Amber ff99ildn forcefield for the protein, whilst in this study we have used 
ff14. In general the results obtained for all ligands are consistent but two ligands at either end of the rankings, THQ9 
and THQ15, differ significantly as shown in Fig. 6b. The ranking performance with ff99ildn is described in Table 6. 
Comparing to those for ff14 (the THQ subset values in Table 4) shows ff99ildn provides better results, especially those 
for 2traj-ar in the 4BJX model (rs of 0.80 compared to 0.46). There are many factors which may cause this difference but 
one we identified was the possibility that the balance between direct and water mediated interactions might be altered 
by modifications to the amino acid side chain parameters. This in part motivated our investigation of the impact of 
including explicit water molecules in the receptor component of our calculations (see the following section).
Ligand ID pIC50 ΔGexpt (kcal mol−1)
Diverse (DIV)
1 — −9.8 (0.1)
2 — −9.6 (0.1)
3 — −9.0 (0.1)
4 — −8.9 (0.1)
5 — −8.8 (0.1)
6 — −8.2 (0.1)
7 — −7.8 (0.1)
8 — −7.4 (0.1)
9 — −7.3 (0.1)
10 — −6.3 (0.1)
11 — −5.6 (0.1)
Tetrahydroquinoline scaffold (THQ)
THQ1 7.0 −9.6 (0.1)
THQ2 5.6 −7.7 (0.1)
THQ3 6.8 −9.3 (0.1)
THQ4 6.8 −9.3 (0.1)
THQ5 7.9 −10.8 (0.1)
THQ6 5.6 −7.7 (0.1)
THQ7 5.8 −8.0 (0.1)
THQ8 6.5 −8.9 (0.1)
THQ9 <4.3 >−5.9 (0.1)
THQ10 7.6 −10.4 (0.4)
THQ11 6.8 −9.3 (0.1)
THQ12 5.5 −7.5 (0.1)
THQ13 5.4 −7.4 (0.1)
THQ14 6.7 −9.2 (0.3)
THQ15 7.8 −10.7 (0.1)
THQ16 5.4 −7.4 (0.4)
Table 3. Experimental binding affinities for both the diverse (DIV) and tetrahydroquinoline scaffold (THQ) 
datasets. The values used here were taken from Aldeghi et al.15 for the DIV and Wan et al.9 for the THQ datasets 
respectively. Values for ligands 1–4 and 6–8 were derived from ITC experiments, 5 from SPR and 9–11 from 
Alphascreen. All THQ values were derived from IC50 values from FRET experiments.
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Inclusion of explicit Water. Aldeghi et al.22 found that the inclusion of explicit water molecules as part of 
the receptor in MMPBSA calculations improved the correlation with experiment in the DIV dataset. Here we 
explore whether this finding is reproducible using ensemble simulations and is robust to the addition of THQ 
ligands to the dataset under investigation. We use the same strategy in selecting water molecules for inclusion as 
the previous work, namely using the closest N to the ligand in each frame of the simulation trajectory.
We found a large difference in the impact of explicit water molecules between the combined DIV + THQ and 
DIV alone datasets. The correlations within the THQ dataset do not benefit from the inclusion of the additional 
water molecules in any protocol. For the combined dataset we find that up to around 5 explicit water molecules 
improves the rankings for all protocols (see Fig. 7a). After 50 water molecules are included 1traj performance 
drops to show no significant correlation with experiment and is only slightly improved as more molecules are 
added. A similar pattern is observed for the 1traj-ar and 2traj-ar results although, after the initial improvements, 
performance is more stable until 100 water molecules are included when an even sharper fall off is observed.
For the DIV dataset as shown in Fig. 7b the improvements are yet more marked. The biggest improvement is seen 
in the 1traj results. Furthermore, the MUE for these rankings does not increase with adding more water near peak 
performance 3.38/3.54 for 0 and 3.08/3.08 for 5 water molecules (2OSS/4BJX). In line with the results of Aldeghi et al.22 
Protocol Dataset cMUE* PI r rs
2OSS Structure
1traj
DIV + THQ 3.25 (0.51) 0.48 0.51 (0.16) 0.46 (0.18)
DIV 3.38 (0.68) 0.74 0.64 (0.19) 0.69 (0.23)
THQ 2.01 (0.37) 0.11 0.19 (0.22) 0.09 (0.27)
1traj-ar
DIV + THQ 3.30 (0.49) 0.62 0.61 (0.14) 0.60 (0.14)
DIV 3.98 (0.68) 0.75 0.67 (0.18) 0.72 (0.19)
THQ 2.05 (0.30) 0.46 0.47 (0.17) 0.42 (0.22)
2traj-ar
DIV + THQ 3.57 (0.54) 0.65 0.62 (0.12) 0.66 (0.11)
DIV 4.09 (0.78) 0.66 0.62 (0.18) 0.64 (0.21)
THQ 2.41 (0.67) 0.67 0.54 (0.13) 0.65 (0.17)
2traj-fl
DIV + THQ 3.33 (0.59) 0.59 0.55 (0.14) 0.57 (0.14)
DIV 3.41 (0.88) 0.75 0.59 (0.19) 0.72 (0.20)
THQ 2.09 (0.55) 0.41 0.40 (0.17) 0.39 (0.23)
4BJX Structure
1traj
DIV + THQ 3.32 (0.53) 0.48 0.50 (0.17) 0.46 (0.18)
DIV 3.54 (0.80) 0.79 0.65 (0.18) 0.74 (0.20)
THQ 2.14 (0.43) 0.07 0.11 (0.24) 0.04 (0.27)
1traj-ar
DIV + THQ 4.05 (0.48) 0.52 0.56 (0.14) 0.49 (0.15)
DIV 3.51 (0.78) 0.60 0.68 (0.18) 0.55 (0.27)
THQ 2.55 (0.46) 0.24 0.30 (0.18) 0.16 (0.25)
2traj-ar
DIV + THQ 3.97 (0.44) 0.61 0.63 (0.12) 0.60 (0.13)
DIV 3.42 (0.82) 0.57 0.67 (0.17) 0.55 (0.24)
THQ 2.70 (0.48) 0.51 0.51 (0.15) 0.46 (0.22)
2traj-fl
DIV + THQ 3.46 (0.51) 0.54 0.56 (0.14) 0.52 (0.16)
DIV 3.52 (0.86) 0.75 0.63 (0.18) 0.73 (0.20)
THQ 2.20 (0.56) 0.27 0.36 (0.19) 0.22 (0.26)
Table 4. Performance of different MMPBSA based ESMACS protocols in reproducing experimental binding 
free energies, measured by mean unsigned error (MUE), Pearson’s predictivity index (PI), correlation coefficient 
(r) and Spearman’s rank coefficient (rs). Bootstrapped error provided in brackets where appropriate. Results are 
provided for the diverse (DIV) and tetrahydroquinoline (THQ) datasets and both combined (DIV + THQ). 
*MUE corrected for mean signed error in kcal mol−1.
Protocol cMUE* PI r rs
1traj 3.57 (0.72) 0.67 0.65 (0.20) 0.61 (0.26)
1traj-ar 5.16 (2.18) 0.62 0.42 (0.22) 0.56 (0.26)
2traj-ar 5.16 (2.22) 0.62 0.39 (0.21) 0.56 (0.27)
2traj-fl 3.49 (0.78) 0.68 0.61 (0.19) 0.62 (0.26)
Table 5. Performance of different MMPBSA based ESMACS protocols in reproducing experimental binding 
free energies using the AM1-BCC method to parameterize ligands. Performance is measured by mean unsigned 
error (MUE), Pearson’s predictivity index (PI), correlation coefficient (r) and Spearman’s rank coefficient (rs). 
Bootstrapped error shown in brackets where appropriate. Results are provided for the diverse (DIV) dataset 
alone bound to protein models based on PDB 2OSS. *MUE corrected for mean signed error in kcal mol−1.
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the peak performance has > .r 0 9s ; however, unlike in the previous work here we see this at 2 water molecules included 
with a decline after 5 (as opposed to a peak at 20 and consistent performance thereafter). A number of factors could 
impact this including our use of ensembles of 4 ns trajectories (compared to single 16 ns runs) and Gaussian/RESP 
charges (as opposed to AM1-BCC). Overall though, it is important to retain at least four of the conserved water mole-
cules in the binding site for the ESMACS calculations in order to obtain consistently good rankings across datasets. 
Moreover, the impact of adding water molecules differs between runs initiated with different starting structures, as 
shown in Table 7.
Protocol cMUE* PI r rs
2OSS Structure
1traj 2.16 (0.39) 0.35 0.31 (0.21) 0.28 (0.25)
1traj-ar 2.62 (0.51) 0.28 0.37 (0.18) 0.25 (0.24)
2traj-ar 2.45 (0.48) 0.60 0.54 (0.13) 0.58 (0.17)
2traj-fl 2.21 (0.36) 0.53 0.50 (0.17) 0.45 (0.23)
4BJX Structure
1traj 2.00 (0.38) 0.33 0.31 (0.21) 0.26 (0.24)
1traj-ar 1.73 (0.33) 0.69 0.62 (0.11) 0.58 (0.18)
2traj-ar 1.79 (0.41) 0.84 0.77 (0.07) 0.80 (0.10)
2traj-fl 2.09 (0.37) 0.55 0.51 (0.16) 0.47 (0.22)
Table 6. Performance of different MMPBSA based ESMACS protocols in reproducing experimental binding 
free energies using the ff99ildn protein forcefield. Performance is measured by mean unsigned error (MUE), 
Pearson’s predictivity index (PI), correlation coefficient (r) and Spearman’s rank coefficient (rs). Bootstrapped 
error provided in brackets where appropriate. Results are provided for the THQ dataset alone bound to protein 
models based on both PDBs 2OSS and 4BJX. *MUE corrected for mean signed error in kcal mol−1.
Figure 5. Comparison of experimental and computed binding affinities for the combined DIV (circle) and 
THQ (triangle) datasets. Computational results were obtained using (a) 1traj and (b) 2traj-ar MMPBSA based 
ESMACS protocols. Results are shown for simulations initiated from models based on PDBs 2OSS (green) and 
4BJX (purple). Solid lines represent lines of best fit, dashed ones optimal correlations.
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The combined DIV + THQ 4BJX 1traj ranking shows only a consistent result, with no improvement, as the 
first 5 water molecules were incorporated, whereas in 2OSS the ranking improves from an rs of 0.46 [CI: 0.16–
0.84] to 0.54 [CI: 0.16–0.84] after the first two water molecules are included. In 1traj-ar the 4BJX results improve 
Protocol No. Water
2OSS 4BJX
cMUE* rs cMUE* rs
1traj
0 3.25 (0.51) 0.46 (0.18) 3.32 (0.53) 0.46 (0.18)
1 3.59 (0.45) 0.52 (0.16) 3.62 (0.46) 0.46 (0.17)
2 3.76 (0.47) 0.54 (0.16) 3.78 (0.48) 0.48 (0.17)
3 3.91 (0.48) 0.51 (0.16) 3.88 (0.49) 0.48 (0.16)
4 4.01 (0.50) 0.52 (0.16) 3.96 (0.50) 0.48 (0.16)
5 4.11 (0.52) 0.52 (0.15) 4.03 (0.50) 0.47 (0.17)
2traj-ar
0 3.57 (0.54) 0.66 (0.11) 3.97 (0.44) 0.60 (0.13)
1 3.70 (0.43) 0.65 (0.11) 4.14 (0.41) 0.64 (0.12)
2 3.96 (0.45) 0.70 (0.11) 4.62 (0.47) 0.67 (0.12)
3 4.28 (0.49) 0.68 (0.12) 5.04 (0.52) 0.67 (0.12)
4 4.57 (0.51) 0.68 (0.12) 5.35 (0.56) 0.66 (0.12)
5 4.79 (0.54) 0.68 (0.12) 5.59 (0.58) 0.66 (0.12)
Table 7. Performance of 1traj and 2traj-ar MMPBSA based ESMACS protocols in reproducing experimental 
binding free energies incorporating different numbers of explicit water molecules. Performance is measured 
by mean unsigned error (MUE) and Spearman’s rank coefficient (rs) (bootstrapped error provided in brackets). 
Results are provided for the combined diverse (DIV) and THQ datasets bound to protein models based on both 
PDBs 2OSS and 4BJX. *MUE corrected for mean signed error in kcal mol−1.
Figure 6. Comparison of 1traj ESMACS results using different forcefield choices. In (a) the ranking of the 
DIV dataset is shown with the same protein forcefield (ff14) but different ligand parameterization methods 
(Gaussian-RESP in dark green, AM1-BCC in lighter green). In (b) results for the THQ dataset are compared 
using the ff14 (dark green is based on PDB 2OSS, purple on 4BJX) and ff99ildn (cyan based on PDB 2OSS, 
orange on 4BJX) forcefields. Solid lines represent lines of best fit, dashed ones optimal correlations.
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from a lower baseline rapidly whilst those from 2OSS remain consistent until 5 water molecules are added, at 
which point the results from both structures give an rs of around 0.6. A similar pattern is seen in 2traj-ar, but with 
the peak performance at 2 water molecules of 0.70 [CI: 0.54–0.97]/0.67 [CI: 0.49–0.96] (2OSS/4BJX) as shown 
in Table 7. The increase in MUE which accompanies the improvement in correlation indicates that the effects are 
not uniform across all ligands. Marginal gains in correlation coefficient should not be over emphasized (as can be 
seen in Table 7, improvements are often within error); we rather wish to draw attention to the trend that inclusion 
of water molecules likely to be involved in mediating stable ligand-protein interactions improves (or at least does 
not degrade) calculation performance. The most important observation is that the addition of explicit water mol-
ecules improves the reproducibility of the ranking when using different starting models.
Figure 7. Impact of the inclusion of explicit water molecules as part of the receptor in ESMACS calculations on 
the Spearman rank coefficient (rs), exhibited for both (a) combined DIV and THQ and (b) DIV alone datasets. 
Results are shown for simulations initiated from models based on PDBs 2OSS (green) and 4BJX (purple) and 
three protocols; 1traj (circles), 1traj-ar (triangles) and 2traj-ar (squares). Main figures show detailed view of the 




cMUE* rs cMUE* rs
1traj
0 2.86 (0.34) 0.34 (0.20) 2.87 (0.41) 0.35 (0.20)
2 4.66 (1.34) 0.19 (0.22) 4.37 (1.14) 0.24 (0.22)
5 5.07 (1.35) 0.14 (0.21) 4.80 (1.39) 0.18 (0.21)
2traj-ar
0 3.35 (0.51) 0.43 (0.16) 3.39 (0.41) 0.46 (0.16)
2 5.57 (1.37) 0.30 (0.19) 4.70 (0.99) 0.40 (0.19)
5 5.57 (1.48) 0.35 (0.20) 5.35 (1.11) 0.46 (0.18)
Table 8. Performance of 1traj and 2traj-ar MMPBSA based ESMACS protocols in reproducing experimental 
binding free energies incorporating both variational entropy and different numbers of explicit water molecules. 
Performance is measured by mean unsigned error (MUE) and Spearman’s rank coefficient (rs) (bootstrapped 
error provided in brackets). Results are provided for the combined diverse (DIV) and THQ datasets bound to 
protein models based on both PDBs 2OSS and 4BJX. *MUE corrected for mean signed error in kcal mol−1.
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Variational entropy. Accounting correctly, and computationally efficiently, for the entropic component of 
binding free energies remains a challenge for MMPBSA based computations. Here we investigated the use of 
the variational entropy technique on the ranking of different ESMACS protocols. In all cases the variational 
entropy was computed using the fluctuations from the 1traj simulations. As shown in Table 8 the inclusion of 
this term results in a reduction in the performance of all protocols in simulations based on both initial models. 
Furthermore, the incorporation of explicit water molecules into the receptor reduces this to an even greater 
extent. Looking in more detail we see that some compounds suffer a deterioration in prediction whilst others 
manifest an improvement. For instance, Fig. 8 shows that the three DIV outliers 3, 4 and 5 are closer to the trend 
line than in Fig. 5, whereas THQ12 and THQ13 are more poorly predicted. The entropic term is based on the 
variation in interaction energy during the complex simulation. As it compares versus the average it captures 
properties of the interaction energy surface. For molecules such as 6, 8, 9 and 10 that have few degrees of freedom, 
the interaction energy surface is likely to be steep, with small changes in conformation or translations leading to 
a rapid loss of interaction energy. Meanwhile, larger more flexible compounds such as 4 and 5 (which has a flexi-
ble benzhydryl core) can adapt to conformational changes of the receptor and maintain a favourable interaction 
energy, leading to a flatter potential surface. The results suggest that this entropic term is suited to the latter but 
not the former examples. Correctly capturing entropic contributions is key to obtaining truly reliable rankings 
in diverse datasets and further work in this area is required. Also, components of the MMPBSA calculation (par-
ticularly the surface area term) incorporate some entropic contributions and such double counting may account 
at least in part for the poor performance of variational entropy here.
Discussion
In summary, we have investigated the influence of different analysis choices on the results of ensemble MMPBSA 
based free energy calculations. The basis of our tests are two datasets which cover common computational chem-
istry challenges - one which is based on a set of related ligands and the other a highly diverse set of ligands with 
differing binding modes. In order to obtain successful rankings across the two datasets we found it necessary to 
incorporate receptor and ligand strains. Using the 2traj-ar ESMACS protocol we obtained Spearman correlations 
of between 0.60 [CI: 0.46–0.91] and 0.66 [CI: 0.50–0.94] for two different starting structures despite differences 
in charge and scaffold in the ligands. The lower confidence bounds of both these estimates are comparable to the 
average correlation coefficient from the 1traj protocol 0.46 [CI: 0.16–0.84], suggesting the result is statistically 
Figure 8. Comparison of experimental and computed binding affinities incorporating variational entropy for 
the combined DIV (circle) and THQ (triangle) dataset. Computational results obtained using (a) 1traj and (b) 
2traj-ar MMPBSA based ESMACS protocols. Results are shown for simulations initiated from models based on 
PDBs 2OSS (green) and 4BJX (purple). Solid lines represent lines of best fit, dashed ones optimal correlations.
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significant despite the relatively modest size of the dataset (which contains a total of 27 ligands). It should be 
noted that increase in computational cost is minimal here as the only additional simulations required are of the 
ligand (which are much smaller than either complex or receptor) with the receptor energy replaced by a con-
stant. Hence, for prospective day to day applications, we recommend accounting for both ligand and receptor 
strain through independent ligand simulations and either further simulation of the apo receptor (as in the 3 traj 
ESMACS protocol) or the use of an average value for the receptor energies (2traj-ar).
A key consideration in the use of binding free energy calculations in real world (industrial or clinical) settings 
is the reproducibility of the results. Other considerations include computational cost and calculation stability. 
ESMACS protocols offer advantages in both these regards as they make use of relatively simple and fast classical 
MD simulations compared to many parallel simulations of intermediate states as required in alchemical calcu-
lations of absolute binding free energies44. We have shown that the results obtained in this study are robust to 
changing the ligand charge generation protocol (to use AM1-BCC instead of Gaussian/RESP) and the forcefield 
used to parameterize the protein (from Amber ff14SB to ff99SBildn). The use of ensemble simulations is the key 
to obtaining this reproducibility as individual replicas in ensembles varied by as much as 15 kcal mol−1 (which is 
in line with our own and other groups previous results9,16,18,45). Despite this, performance differences were found 
for all initial protocols when simulations were initiated from different crystal structures.
This observation, along with the fact that some ligands which have very similar experimental binding ener-
gies were widely separated even using protocols which accounted for receptor flexibility (1traj-ar and 2traj-ar), 
prompted us to investigate potential enhancements of the pure MMPBSA protocol. Specifically, we looked at the 
inclusion of an explicit ligand hydration shell in the receptor and variational entropy which had previously been 
investigated for single replica simulations by Aldeghi et al.22 (though they also only investigated what we would 
term “1traj” calculations). These additional components capture chemical and physical features of the system 
neglected by MMPBSA but at minimal computational cost, a key consideration for practical binding affinity cal-
culation applications. The entropy term reduced extreme outliers but at the expense of decreased overall ranking 
performance. This observation replicates that obtained by Aldeghi et al.22 for the DIV dataset bound to BRD4, 
although they found the term improved results for sensitivity based datasets including multiple proteins. When 
less than five water molecules were incorporated into the receptor our rankings were improved with the best 
ranking across the full dataset obtained using this in combination with the 2traj-ar protocol. The most important 
observation of our work, however, is that the inclusion of these bound water molecules considerably reduced 
the performance difference between simulations initiated from models based on different crystal structures. A 
criticism of continuum based methods is that they are incapable of capturing the effect of crucial water molecules, 
possible activity cliffs, etc, that are now a well understood feature of structure-activity relationship (SAR) land-
scapes and medicinal chemistry lead optimization. Here it is shown again how this challenge can be met, with 
the simple inclusion of explicit water molecules. Future work should address how to consider this in prospective 
application scenarios and in a wider range of protein targets.
The reason for the improved performance observed for the diverse datasets in this study is presumably due to 
the capture of interactions between the ligand and the closest of the four conserved water molecules also found in 
the binding site. This observation is in line with other work in which system dependent numbers of water mole-
cules were found to improve rankings46–49 and the broader phenomenon of the impact of crucial water molecules 
on SAR landscapes. Incorporation of the water molecules was highly effective in differentiating the ligands with 
diverse binding modes but less effective in the set of related THQ-scaffold based compounds. The fact that our 
observations fit a general pattern, and that the level of explicit water hydration which improves results is similar 
to the number of conserved water molecules suggests that the approach can be applied more generally.
Overall we have shown that, for a diverse set of ligands, in order to deliver reproducible results from ESMACS 
(MMPBSA) calculations it is necessary to account for receptor and ligand strain and account explicitly for water 
molecules bound alongside ligands. Essential to obtaining these results is the use of ensemble simulations to gen-
erate meaningfully quantified uncertainties.
Data Availability
Simulation input topologies and coordinates (alongside ligand parameters) for all protein-ligand systems and 
collated MMPBSA results are made available via Zenodo, 10.5281/zenodo.1484050. Trajectories are available 
from the corresponding author on reasonable request.
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